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The Role of Transcatheter Aortic Valve Replacement in Heyde Syndrome
Keval Patel M.D., Joseph Abbo M.D.,
Imtiaz Ali D.O., Rajika Munasinghe M.D.
Henry Ford Health System, Detroit, Michigan
Abstract
Introduction: This is a case of a pleasant 81 year-old male who
presented to the ED complaining of chest pain with activity for the
past 3-4 weeks. He reports of chest pain with minimal exertion of
walking across the parking lot to the car. This has been a substantial
change from his baseline, he currently works as a mason. He was
referred to the ED by his primary care physician after having
abnormal lab result showing low hemoglobin of 7.6. During the
admission he underwent work up of his chest pain and symptomatic
anemia. The patient’s anemia was attributed to intestinal
arteriovenous malformations seen in the cecum and ascending colon
during colonoscopy. He had a 2-D ECHO showing severe aortic
valve stenosis. The patient was diagnosed with Heyde syndrome
which is the association acquired von Willebrand deficiency with
aortic stenosis and gastrointestinal angiodysplasia. Here we discuss
the pathophysiology of Heyde syndrome and the role of TAVR in
treatment of our patient.

Presentation
Patient is a 81 year old male with a past medical history of hypertension,
hyperlipidemia, chronic kidney disease stage 2, skin cancer (diagnosed in 2014)
and BPH who presented to the hospital with chief complaint of chest pain on
exertion. He states that he has been having chest pain with normal daily activity
for the past 3-4 weeks. The chest pain is described as localized pressure to the
chest and is nonradiating in nature. He denies any associated shortness of
breath with this chest pain. On presentation the pain was rated a 6/10. He notes
that the chest pressure occurs after taking about 70 steps which has
significantly reduced his work as a mason. The pain is relieved after several
minutes of rest. More recently his chest pain required longer rest time to
resolve which prompted him to visit his primary care physician. several days
prior to presentation. Lab work was collected at the PCP office and he was
given referral to follow with a cardiologist. Upon visit to the cardiologist’s
office he was scheduled for a pharmacologic stress test in 1 month and was
prescribed Imdur 30mg daily. He had taken the Imdur as prescribed without
significant relief. The morning of presentation he received a call from his PCP
of an abnormal lab result, hemoglobin of 7.6. He denied any other complaints
of fevers, chills, sweats, nausea, vomiting, headache, lightheadedness,
dizziness, visual changes, palpitations, paroxysmal nocturnal dyspnea,
orthopnea, shortness of breath, hemoptysis, abdominal pain, changes in bowel
habits, melena, hematochezia, leg pain/cramping.

Discussion

Pertinent Testing

Heyde syndrome is a multisystemic disorder characterized by the triad of aortic
stenosis (AS), gastrointestinal bleeding and acquired von willebrand syndrome.
It is suspected that Heyde syndrome occurs as a result of the increased force
through the stenotic aortic valve that results in cleavage of large von
Willebrand multimers. The increased shear force is thought to cause
transformation of the von Willebrand factor into an uncoiled form in plasma.
This uncoiled von Willebrand factor is recognized by a plasma protease,
ADAMTS13 which binds to the A2 domain resulting in cleavage of the von
Willebrand factor. As a result, the von Willebrand multimers are reduced in
size and become less able to maintain hemostasis. (11)
Angiodysplasia is thought to be common in vascular aging. It is suspected that
the combination of vascular aging and the acquired von Willebrand factor
deficiency from the shear force of stenotic aortic valve results in bleeding from
the angiodysplastic lesions. In a study of patients diagnosed with
angiodysplasia of the GI tract over 10 years, ECHO significantly correlated
with aortic stenosis. (9).
The role of transcatheter aortic valve replacement (TAVR) in Heyde syndrome
is the correction of the underlying AS. Of the triad of Heyde’s syndrome the
valvular disorder remains the component that maybe the easiest to address at
this time. TAVR is a minimally invasive procedure that involves placement of
a new aortic valve over the existing stenotic valve with the ultimate goal of
reduction in peak gradient through the valve. A retrospective study of 91
patients with AS and chronic unexplained GI bleeding showed that bleeding
ceased in 93% of patients treated with valve replacement. (10) Replacement of
this valve can result in removal of one of the causes of increased shear forces
on the large von Willebrand factor multimers.
Post-TAVR our patient has maintained his hemoglobin levels and has not had
any further hospitalizations for symptomatic anemia.

• Upon presentation EKG showed Normal sinus rhythm without any ST
changes.
• He was initially started on 1 unit PRBC transfusion.
• Iron Studies: Iron 10 ug/dL, Ferritin 8 ng/mL, Iron Saturation 2%
• Stool guaiac positive
• He underwent EGD and colonoscopy. EGD showed no inflammation,
ulceration, mass lesions or scalloping of the folds. Colonoscopy showed
significant number of arteriovenous malformations in the right colon,
unclear of AVMs in the small bowel.
• ECHO which revealed severe aortic stenosis with peak aortic velocity of
4.48 m/s and peak/mean gradient 80.1 mmHg/ 49.8 mmHg. Calculated
aortic valve area 0.81 cm2.
• TEE: LVEF 58%, severe calcific tricuspid aortic valve stenosi.
• Left heart Cardiac Catheterization: Mild nonobstructive coronary artery
disease with severe aortic valve stenosis and mild pulmonary hypertension.
• von Willebrand Factor antigen pre TAVR: 187%
• von Willebrand Factor antigen post TAVR : 140%
• Post TAVR ECHO: LVEF 58%, Peak gradient 29.6 mmHg, mean gradient
14.3 mmHg

Photos

Hospital Course

During hospitalization he was noted to be anemic and have hemoglobin of 7.5
on presentation. He was transfused 2 units packed red blood cell. He
underwent colonoscopy which revealed multiple AVMs in the right colon.
There was no plan for capsule endoscopy. ECHO revealed severe calcific
tricuspid aortic valve stenosis. He did undergo outpatient iron supplementation
for iron deficiency anemia. He underwent outpatient cardiology evaluation for
aortic valve replacement and later a transcatheter aortic valve replacement.

Conformational Change and Proteolytic Cleavage of von Willebrand Factor in
Aortic-Valve Stenosis (5)
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